Constellation is a flexible, robotic end-to-end cell therapy automation platform, integrating proven tools and processes to scale manufacture.
Total raised: $40M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.12.2025 | Series A | $40M | Johnson &a... |
Mentions in press and media 3
| Date | Title | Description |
| 16.12.2025 | Cellular Origins Raises USD 40M in Series A Funding | Cellular Origins, a Cambridge, UK-based company that enables the manufacturing of cell therapies at scale, raised USD 40M in Series A funding. The round was led by Johnson & Johnson, through its corporate venture capital organisation, J... |
| 31.05.2023 | Cellular Origins launches Constellation, its configurable robotic platform to enable scalable manufacture of advanced therapies | Closed, fully automated, and configurable robotic platform for cell therapy manufacture can achieve 30-fold increase in space efficiency and reduces production costs and labour by 51% and 16-fold respectively Scales cell therapy manufacturi... |
| - | Cellular Origins | “Constellation is a flexible, robotic end-to-end cell therapy automation platform, integrating proven tools and processes to scale manufacture.” |